DUBLIN, March 17, 2022 /PRNewswire/ — Perrigo Company plc (NYSE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it has received final approval from the U.S. Food and Drug Administration for the…Original Article
FDA Approves Nasonex 24HR Allergy (mometasone furoate) Nasal Spray for OTC Use
